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Abstract
OBJECTIVE: Clinical success of atrial ﬁbrillation (AF) ablation depends on persistent block of electrical conduction across the ablation lines.
The fate of ablations performed with temperature-controlled bipolar radiofrequency (RF) is unknown. The purpose of this study was to val-
idate the electrophysiological (EP) efﬁcacy of these lesions, recording pulmonary vein isolation (PVI) after open chest ablation, in the
human being.
METHODS: Ten consecutive mitral patients (mean age: 53 ± 12 years) with concomitant AF were treated with the Cobra Revolution
(Estech, San Ramon, CA, USA) bipolar RF device were enrolled for EP assessment. During surgery, pairs of additional temporary wires were
positioned on the right PVs (RPV) and on the roof of the left atrium (RLA), before ablation. Pacing thresholds (PTs) were assessed before,
after a single encircling ablation and at chest’s closure. EP study was repeated before discharge and at 3 weeks. RLAwires served as control.
RESULTS: Baseline PTs were 0.83 ± 0.81 mA (range 0.2–3 mA) from RPV and 1.13 ± 0.78 mA (range 0.3–3 mA) from RLA. PVI was reached in
all patients acutely, and was maintained at 1 week. At 3 weeks, the PTs were 14.3 ± 4.3 mA from RPV (range 7–20 mA) and 3.1 ± 1.3 mA
(range 1.5–7 mA) from RLA. All patients were discharged in sinus rhythm.
CONCLUSIONS: Cobra Revolution temperature-controlled bipolar RF provides complete PVI after a single ablation up to 1 week. This not-
withstanding, only 30% of patients were completely isolated (exit block validation) at 3 weeks.
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INTRODUCTION
Durable transmurality of the ablation lines is considered the gold
standard for the current treatment of atrial ﬁbrillation (AF). One of
the key aspects of AF treatment consists in ablating the pulmonary
vein (PV) ostia, generally one of the thickest areas of the left
atrium, obtaining their electrical disconnection [1–3]. Many
technological reﬁnements were introduced in recent years to
ameliorate the efﬁcacy of ablative energy sources, in particular
bipolar radiofrequency (RF) lesions proved to be reproducibly
transmural and contiguous on the cardiac muscle [4, 5]. It is
fundamental for surgeons to know and report which are the
electrophysiological (EP) properties of the ablative platforms
available in the operating room, to compare and to share these
results with the ablations performed in the EP laboratories. The
Cobra Revolution (Estech, San Ramon, CA, USA) ablative platform
uses temperature-controlled bipolar RF. The concept of this
technology is to maintain the ablated myocardial tissue at safe yet
effective temperatures, to ensure reproducible transmural (full-
thickness) endo-epicardial lesions, either on the beating or on
arrested heart. The purpose of this study was to validate the (EP)
fate of these lesions, by assessing the evolution of the conduction
across the right PV ablation, after open chest ablation. This was
obtained using the same protocol used by our group to evaluate
two other energy sources in 2009 and 2012, by pacing from add-
itional strategically positioned atrial temporary wires, repeating
the EP studies till the third week after ablation [6–7]. The EP prop-
erties of this device after one single ablation have never been
studied.
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MATERIALS ANDMETHODS
Patients
Ten patients underwent mitral valve surgery and concomitant AF
treatment with temperature-controlled RF, from December 2012
to February 2014. Indication for ablation was paroxysmal and per-
sistent AF. Preoperative data were similar to those described in [7],
details of all patients undergoing the coronary angiography, trans-
oesophageal echocardiography (also to rule out atrial appendage
thrombi) and 24-h Holter monitoring are summarized in Table 1.
The study protocol was approved by our Institutional Review
Board, and informed written consent was signed by each patient
before surgery. All enrolled patients agreed to stay at our institu-
tion until completing the postoperative rehabilitation period. At
follow-up, a 12-lead electrocardiogram, 24-h Holter monitoring
and transthoracic echocardiography were performed at 3, 6 and
12 months after surgery.
System description and surgical technique
All the ablations were performed in the same way, by the same
surgeon (Stefano Benussi). The single encircling ablation around
the right PV (RPV) and then on the left PV oriﬁces were per-
formed epicardially, on cardiopulmonary bypass before aortic
cross-clamping and before opening the left atrium, using the
Cobra Revolution (Estech) temperature-controlled bipolar RF ab-
lation platform. This was the lesion set performed for the parox-
ysmal AF patients. The 3 patients with early persistent AF had a
left lesion set done under complete cardioplegic arrest. The left
atrium was opened with an extended incision parallel to the
Waterston groove. A mitral ablation line was then carried out by
clamping the left atrial wall in an endo-epicardial fashion with
bipolar RF, doubled thereafter with cryoenergy. Cryoablation of
the AV groove is adopted to adhere to the original maze
technique, as described by Cox et al. [8]. It is in fact a mainstay
of all known iterations of the maze operation, adopted to have a
better penetration of the ablations in the thickest and fattiest
area of the left atrium—namely, the AV groove—where RF might
not penetrate adequately. Then, two endo-epicardial inter-
pulmonary lines were performed to connect the two encirclings.
One last left atrial appendage (LAA) connecting endocardial ab-
lation was performed by clamping the device with one jaw in
the appendage and one in a left PV [9]. LAA was excluded from
systemic circulation in all patients with a double-layer suture,
except one patient who had his LAA excluded with a TigerPaw™
System II (Maquet, Inc.). Thereafter, the mitral and tricuspid
disease was addressed.
Electrophysiological and clinical assessment
Using the same protocol of research described in 2009 and in
2012 [6–7], after cardiopulmonary bypass was instituted, pairs of
additional temporary wires (6494F, Medtronic, Inc., Minneapolis,
MN, USA) were transﬁxed strategically into two points. The ﬁrst on
the RPVs, was positioned close to their atrial ostium (Fig. 1), to
obtain the diagnostic value. The second pair, as control, was posi-
tioned on the roof of the left atrium (RLA) in proximity to the
Bachmann bundle, outside the left posterior atrial ablation box, in
order to have a control EP value. Pacing thresholds (PTs) from all
atrial wires were assessed at baseline and immediately after one
single encircling ablation of the RPVs, using an external temporary
pulse generator (5833, Medtronic, Inc.).
Further, the same assessment was repeated after chest closure
and after removal of chest drains, to rule out possible dislodge-
ment of the wires, before discharge from the division and 3
weeks after surgery, before leaving the rehabilitation unit of our
hospital.
By deﬁnition, exit block was considered signiﬁcant when no
capture was obtained at 20 mA, the maximum output of our pulse
generator [10]. After completing the 3 weeks control, the wires
were removed and a transthoracic echocardiogram was per-
formed the following day to rule out pericardial collection, before
discharge.
Table 1: Preoperative data
Variables N
Number of patients 10
Age (years) 53 ± 12
Female gender 5 (50%)
NYHA class
I 1 (10%)
II 8 (40%)
III 1 (10%)
Duration of atrial fibrillation (months) 30.7 ± 5.1
Atrial fibrillation type
Paroxysmal 7 (70%)
Persistent 3 (30%)
Valvular heart disease
Mitral 10 (100%)
Tricuspid 3 (30%)
Degenerative/rheumatic valve disease 7/3
Left atrial diameter (mm) 47 ± 5
Left atrial volume (mm) 80 ± 47
Telediastolic left ventricular diameter (mm) 63 ± 6
Ejection fraction (%) 55 ± 4
Values are expressed as number and (percentage) for discreet variables
and as mean ± standard deviation for continuous variables.
Figure 1: Right pulmonary vein ablation performed by temperature-controlled
bipolar radiofrequency device after positioning of a pair of temporary wires on
the right pulmonary veins.
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Data analysis
No formal sample size calculation was performed. The study was
designed as a pilot study as no previous data were available.
Statistical analysis was conducted using the JMP 8.0 package (SAS
Institute, Inc., Cary, NC, USA). Shapiro–Wilk test was used to assess
the normality of all the data samples. All results are generally
expressed as mean ± standard deviation (range) for continuous
variables and as proportion (%) for categorical variables. Patients
had been followed for the follow-up through 15 March 2014.
RESULTS
Clinical
As performed in our previous report on the EP efﬁcacy of high-
intensity focused ultrasound (HIFU) energy source [7], 10 patients
were enrolled in this pilot study. Mean age was 53 ± 12 years, 5
(50%) patients were male. No patient had previous transvenous
ablations. There were 7 patients with paroxysmal AF (70%) and 3
patients with persistent AF (30%), who underwent a complete left
atrial maze lesion set with cryoablation of the mitral annulus.
Concerning the mitral pathology, degenerative disease affected 7
patients, who underwent mitral valve repair (central edge-to-edge
technique in 2 cases, quadrangular resection of the posterior leaﬂet
in 5 cases with positioning of neochordae on the anterior leaﬂet in 2
cases) with implantation of a partial ﬂexible ring in all of them; in 3
patients concomitant tricuspid tri-dimensional annuloplasty was
associated. Three patients required mitral valve replacement with
mechanical prosthesis, due to extensive ﬁbrotic degeneration of the
valve apparatus for previous rheumatic disease. The mean extracor-
poreal time was 97 ± 24 min, mean cross-clamping time was
74 ± 21 min. Median postoperative hospitalization was 7 days (range
5–13 days) and all patients were discharged in sinus rhythm.
At a mean follow-up of 12 ± 5 months, 10 patients (100%) were
in sinus rhythm. Of these, 4 (40%) were free from antiarrhythmic
medications. Two patients experienced AF within 3 months after
the operation, treated successfully with direct current (DC) shock.
No permanent pacemaker implantation occurred after surgery.
Adverse events
No early in-hospital death and late adverse events were registered.
Electrophysiological study
During surgery, the mean PTs considered as baseline were
0.83 ± 0.81 mA (range 0.2–3 mA) on the RPV and 1.13 ± 0.78 mA
(range 0.3–3 mA) on the RLA.
Every patient was isolated (PTs = 20) immediately after ablation
and at chest closure and after removal of chest drains (Fig. 2). At
pre-discharge EP study (6 ± 2 days after surgery), the mean RPV
PTs was 20 ± 0 mA (range 1–7.8 mA), complete isolation persisted
in all patients. At the same time, the mean PTs on RLA was
2.7 ± 1.9 mA (range 0.75–7.7 mA). At 3 weeks (23 ± 2.4 days after
surgery), the mean PTs were 14.3 ± 4.3 mA from the RPV and
3.1 ± 1.3 mA from the RLA (range 7–20 and 1.5–7 mA, respectively).
Complete isolation, identiﬁed by absence of ventricular capture
pacing from the RPV leads (PT or exit block equal to 20 mA), was
maintained in 3 patients, the other 7 patients lost the complete
isolation between the ﬁrst and the third week.
After surgery, a slight increase of the PTs from the RLA was
observed, progressively passing from 1.4 mA at baseline to 6.8 mA
at 3 weeks. Likewise, a positive trend in the same time span was
observed for the RLA leads, PTs grew from 1.7 to 6.3 mA. These
results are obtained after one single encircling ablation with
the Cobra Revolution temperature-controlled bipolar RF ablation
platform.
DISCUSSION
Complete electrical isolation of the PVs should be the main
goal in every ablation strategy targeting the left atrium. Its achieve-
ment requires, at least, the assessment and demonstration of
conduction block across the lesions. Following the protocol of
EP investigation conducted at our institution to validate energy
sources [6–7], this is the ﬁrst study to systematically check the EP
properties of the PVs after a single ablation performed with the
Cobra Revolution bipolar temperature-controlled RF. Acute con-
duction block (PTs of the ablation or exit block >20 mA) was
always achieved with this energy source, after a single ablation.
Complete electric block of the PVs was maintained during the ﬁrst
week, as shown at the EP study (Fig. 2). At 3 weeks, only 3 patients
(30%) demonstrated complete pulmonary vein isolation (PVI),
while the other 7 patients (70%) outlined partial PV reconnection
(PTs between 9 and 15 mA). Adopting the same protocol of
Figure 2: Pacing thresholds measured from the atrial wires before and after Cobra Revolution ablation, before discharge, and at 3 weeks.
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investigation, Benussi et al. documented that multiple ablations
with bipolar irrigated RF around the RPV couple reached com-
plete acute isolation in all patients, and it persisted till the third
week in only 62% of patients [6]. The post-acute fate of
temperature-controlled bipolar RF ablations has never been
reported in the clinical setting. Therefore, our results provide sig-
niﬁcant comprehension on the incidence, evolution and charac-
teristics of recovery of PV conduction after one single ablation
with this type of energy. Initially, the inﬂammation masked the
block, which disappeared in most patients during the second to
third week, showing reconnection. Even if different forms of nec-
rotic cell death can be distinguished, based on their initiating
mechanisms (necrosis, necroptosis and secondary necrosis), the
later aspects of the death process that happens after ablation take
place exactly in the same way during the following few hours [11].
Based on the current biological and molecular evidence, the
ablative lesions can only decline thereupon; no described mech-
anism could explain a delayed myocardial cell death, in which the
event occurs during the ablation and the outcome cannot be
detected after 3 weeks. Indeed, ﬁbroblasts should replace only the
necrotic myocytes, while the not-necrotic cells will recover
without ﬁbrosis, leaving a gap (e.g. the inner cells of the thickest
parts of the myocardial muscle). The knowledge of the acute con-
duction properties of ablation platforms registered in the oper-
ation theatre is fundamental, since the electrical disconnection of
the PVs maximizes the chance of ablation success [12, 13]. After
percutaneous ablations, the major predictor of failure is the lack of
PV electrical disconnection after the procedure, indicating recon-
nection of PV conduction or ineffective PV isolation [14, 15].
Moreover, it is demonstrated that repeated ablations in the cath-
eter laboratory improve the success rate of paroxysmal and per-
sistent AF [15–18]. This relationship fosters the central role of
durable isolation of the ablations in the cure of AF. Indeed, the
data on transmurality of beating-heart epicardial ablations with
unipolar devices are all but satisfactory. Although acutely effective
in most cases, epicardial microwave ablation on the beating heart
at times fails to accomplish electrical isolation even after repeat
ablation [19]. This is true also for unipolar RF ablation, due to the
composition and thickness of the atrial wall. The major obstacle to
the progression of the lesion through the subendocardial layer is
the convective cooling exerted by blood ﬂow through the atrial
chamber [20]. Finally, a systematic assessment of post-acute block
after ablation with non-clamping epicardial HIFU, showed a radic-
ally different outcome. In fact, the postoperative EP study revealed
the complete absence of electrical isolation of HIFU ablations, in
both the acute and post-acute phase [7].
To the contrary, bipolar systems are speciﬁcally designed to
work epicardially. The clamping mechanism abates the endocar-
dial convective cooling, and reduces tissue thickness by compres-
sion, at the same time improving contact. In our ﬁrst series
reporting EP acute outcomes of this energy source, PT assessment
showed a complete conduction block in 92% (22/24) of the PV
couples after a single ablation and in 100% after one repeat abla-
tion. This fact suggested that acute conduction block was not con-
stantly maintained in the post-acute phase, even after multiple
parallel ablations in patients with particularly thick tissue around the
PV ostia [21]. Both impedance-guided and temperature-guided
bipolar devices require more than one ablation to achieve acute
conduction block.
The slight increase in PTs occurring in the unablated leads on
the RLA, along the ﬁrst 3 weeks, was consistent with a normal
foreign body reaction around the electrodes. Although not all
patients were completely isolated, all patients were in sinus
rhythm during follow-up. This could be explained by the fact that
the valve was repaired and an adequate ablative lesion set was
performed, so, no other factor should virtually limit the persist-
ence of sinus rhythm. Notably, 4 patients needed AAD to stay in
sinus rhythm. The study was not designed, due to the nature of
valvular patients affected by paroxysmal and early persistent
AF, to do inferences between EP properties and clinical freedom
from arrhythmia. This study has several limitations. First of all, a
small cohort of patients was enrolled. Further, the EP analysis was
performed only on the right PVs and the complete PVI on both
the PV cuff was not available up to 3 weeks after temperature-
controlled RF ablation; moreover, we are unaware of any further
changes in the EP conduction possibly occurring beyond this
period.
In conclusion, Cobra Revolution temperature-controlled bipolar
RF provides complete PVI after a single ablation up to 1 week. This
notwithstanding, only 30% of patients were completely isolated
(exit block validation) at 3 weeks.
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APPENDIX. CONFERENCE DISCUSSION
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Dr T. Weimar (Stuttgart, Germany): Your study perfectly shows that you cannot
always translate animal studies to human beings. There have been animal
studies showing conduction block with one application even chronically on the
beating heart, which you proved is probably not true for the human being.
However, I don’t think that any company or any surgeon would recommend
applying those clamps only once on the pulmonary veins if you use a beating
heart.
I think radiofrequency as well as cryoenergy are well proven and reliable
energy sources; however, the big difference is that extracting the heat by cryoe-
nergy does not really require an algorithm, while this is needed for radiofre-
quency. Again, it does not prove transmurality, it just indicates to the surgeon
changes of conductance or temperature or whatever is used as algorithm.
However, reading through your paper, and you touched most of those
points during your discussions, I would have two questions. Can you comment
on the algorithms, temperature-controlled versus conductive-controlled?
Which algorithm we should go with, ﬁrst of all?
Secondly, I was a little surprised that you had such excellent results. You had
100% sinus rhythm at 12 months, although not all of them were off drugs,
which means our cornerstone PVI seems not as important as we thought? Your
data suggests good results with only 30% of PVs being isolated. Do we overesti-
mate PVI as cornerstone?
Dr Pozzoli: The ﬁrst question was about the temperature control. I cannot
comment very deeply on the physical aspect of temperature-controlled bipolar
radiofrequency, but I can say that the jaws of this clamp are different in respect
to other ablators, with ﬂexible serpentine electrodes. So, in an optic of com-
parison with other clamps available in arrhythmia surgery, it’s a different way of
delivering the energy. So in the thickest regions of the pulmonary veins it could
be challenging to reach the complete transmurality or, in other words the elec-
tric isolation.
Concerning the other question, I think this study was not designed to study
the correlation between the EP properties and the clinical outcomes. So I think
that, if we want to do this inference, we should select patients with early persist-
ent atrial ﬁbrillation, we need different patients from those of the current series.
Most of our patients were paroxysmal with mitral regurgitation. After repair it is
quite easy that they are actually on sinus rhythm, with the use of antiarrhythmic
drugs. So this will be in the future another study. I am also curious in under-
standing how much the complete EP isolation translates in successful clinical
outcomes. From the cath lab we know that if we repeat ablations and we close
gaps, we have better results. In fact, patients who are re-ablated three times
normally obtain better results. So, I think it’s not reliable to use this study, this
data, as answer to your question.
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